Delivery Order 36E79724D0005-36C26124N0512
Award Date
3/18/24
Potential Completion Date
10/15/24
Potential Value
$5.9K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price delivery order contract to Glaxosmithkline, LLC for the supply of FLUARIX flu vaccine. The $19,590 contract has an expected completion date of October 15, 2024 and does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that has held multiple federal contracts and grants to provide vaccines, antivirals, and other medical products to government agencies like the Departments...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a firm fixed price delivery order to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for the provision of FLUARIX influenza vaccine. The $58,770 contract has a performance period ending on October 15, 2024 and does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antiviral medications, and other products to U.S....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 has awarded a Firm Fixed Price delivery order contract worth $19,590 to Glaxosmithkline, LLC for the provision of FLUARIX influenza vaccines for individuals 36 months and older. This contract has no set-aside designation and the period of performance runs through October 15, 2024. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antiviral medications, and other...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm fixed price delivery order contract to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide FLUARIX flu vaccine. The $53,872.50 contract has an October 15, 2024 completion date and was awarded on March 19, 2024 with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and vaccines to various government...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 5 to Glaxosmithkline, LLC for the provision of FLUARIX FLU VACCINE. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a potential value of $127,306.08 and a completion date of October 15, 2020. There is no set-aside designation for this award. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has provided a...
The Department of Veterans Affairs Veterans Health Administration has awarded a $7,836 firm fixed price delivery order contract to Glaxosmithkline, LLC for the provision of flu vaccine. The contract has no set-aside designation and is expected to be completed by October 15, 2024. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contract awards, including influenza, hepatitis, and...
The U.S. Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm-fixed-price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of flu vaccines. The contract has a potential value of $80,319.00 and a completion date of October 15, 2024. The contract is not set aside for any specific business type. Glaxosmithkline has provided a range of pharmaceutical products, including vaccines, antiviral...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $186,120 delivery order contract to Glaxosmithkline, LLC for FLUARIX flu vaccine. The firm fixed price contract runs from April 8, 2020 to October 15, 2020 and will be performed in Research Triangle Park, North Carolina. Glaxosmithkline will provide the flu vaccine to support VA-VHA's efforts to serve veterans in the southeastern United States under VISN 5. No major subcontractors or...
This federal contract award is for the influenza vaccine FLUARIX, provided by Glaxosmithkline, LLC to the Department of Veterans Affairs Veterans Health Administration. The $22,038.75 firm fixed price contract has an October 2024 completion date and was awarded on April 9, 2024. There is no set-aside designation. Glaxosmithkline, as the prime contractor, has previously supported U.S. government agency requirements for a range of pharmaceutical products and vaccines, including those related to...
This is a Firm Fixed Price Delivery Order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC for the FLUARIX influenza vaccine. The contract has a potential value of $165,984.00 and a completion date of October 31, 2019. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines and antiviral medications to U.S. government agencies through federal contracts. This award supports the VA's...